SuperworthVistagen Therapeutics market cap VTGN
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $8M
- Highest close in our data
- $648.8M
- Jul 2021
Vistagen Therapeutics is worth $8M at the close on Oct 23, 2026, at $0.18 a share.
That is down 94% over the last year and down 98% over five years.
Its highest close in our data was $648.8M in Jul 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $8M | $8M | $28.8M | −72% |
| 2025 | $28.8M | $28.8M | $193.5M | −60% |
| 2024 | $71.6M | $67.7M | $147.3M | −48% |
| 2023 | $138.9M | $12.5M | $143M | +572% |
| 2022 | $20.7M | $20.7M | $351.5M | −95% |
| 2021 | $389.4M | $150.2M | $648.8M | +171% |
| 2020 | $143.6M | $18.7M | $143.6M | +374% |
| 2019 | $30.3M | $13M | $59.2M | −34% |
| 2018 | $46M | $13.1M | $65.2M | +254% |
| 2017 | $13M | $7.3M | $30.8M | −58% |
| 2016 | $31.3M | $7.9M | $34.7M | +82% |
| 2015 | $17.2M | $6.5M | $23.6M | +56% |
| 2014 | $11M | $7.2M | $19.2M | +8% |
| 2013 | $10.2M | $5.8M | $18.1M | −18% |
| 2012 | $12.5M | $11.2M | $50.3M | −73% |
| 2011 | $46.5M | $34.3M | $47.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Vistagen Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| VTGNVistagen Therapeutics | $8M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Vistagen Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.